carvedilol has been researched along with ferric chloride in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Franconi, F; Tadolini, B | 1 |
| Piccin, A | 1 |
| Cao, JM; Chan, GC; Chan, S; Chen, MP; Cheung, YF | 1 |
3 other study(ies) available for carvedilol and ferric chloride
| Article | Year |
|---|---|
Carvedilol inhibition of lipid peroxidation. A new antioxidative mechanism.
Topics: Antioxidants; Carbazoles; Carvedilol; Chlorides; Ferric Compounds; Ferrous Compounds; Free Radical Scavengers; Hydroxyl Radical; Kinetics; Lipid Peroxidation; Lipid Peroxides; Liposomes; Oxidation-Reduction; Oxygen Consumption; Phosphatidylcholines; Propanolamines; Sonication; Superoxides | 1998 |
Endothelial microparticles and endothelial damage: 'the tip and the iceberg'.
Topics: Adrenergic beta-Antagonists; Apoptosis; Carbazoles; Carvedilol; Cell-Derived Microparticles; Chlorides; Ferric Compounds; Human Umbilical Vein Endothelial Cells; Humans; Propanolamines | 2014 |
Carvedilol protects against iron-induced microparticle generation and apoptosis of endothelial cells.
Topics: Adrenergic beta-Antagonists; Annexin A5; Apoptosis; Carbazoles; Carvedilol; Caspase 3; Cell-Derived Microparticles; Chlorides; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Ferric Compounds; Flow Cytometry; Human Umbilical Vein Endothelial Cells; Humans; Iron Chelating Agents; Iron Overload; Microscopy, Electron, Scanning; Microscopy, Fluorescence; Oxidative Stress; Propanolamines; Propranolol; Reactive Oxygen Species | 2014 |